News Detail
New Delhi, 29 March 2025: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed adver......
View Details
Source : DrugsControl Media Services
Indian Pharmacopoeia Commission
IPC
drug safety alert
March
Metronidazole
Luliconazole
Dalteparin
Gliclazide
Tramadol
adverse drug reactions
ADRs
Pharmacovigilance Programme of India
PvPI database
acute generalized exanthematous pustulosis
chloasma
melasma
Erythema multiforme
Fixed drug eruption
Related News
- 529 Drug Samples declared NSQ and 55 Spurious in last three calendar years in Rajasthan: Govt in LS (31-03-2025)
- WB writes to Bihar and UP governments about spurious drugs makers (31-03-2025)
- Dabur to Drop ‘Anti-Inflammatory’, ‘Anti-Bacterial’, ‘Analgesic’ Claims from Toothpaste Labels by June 2025 (31-03-2025)
- Kangra: One person arrested from Delhi in drug case (30-03-2025)
- RMSCL to address drugs shortage using automated demand system (30-03-2025)
- Raids on chemist shops across Gujarat, 50 lakh Codeine Cough Syrup bottles seized (30-03-2025)
- Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer (30-03-2025)
- HC asks Centre, Delhi govt to disclose regulatory mechanism for blood banks in city (30-03-2025)
- Meghalaya’s Citrus offers hope against antibiotic resistance (30-03-2025)
- Counterfeit anti-rabies vaccine circulating in major Indian cities (30-03-2025)